Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

Jost WH, Bergquist F, Evans A, Hassin-Baer S, Hauser RA, Henriksen T, Malaty IA, Mestre TA, Mir P, Rodriguez R, Schwingenschuh P, Simu M, Bergmann L, Zhou TT, Caughlin S, Gopalkrishnan M, Kukreja P, O'Meara M, Parra JC, Shah MB, Aldred J

Open source

DOI
10.1007/s40120-026-00948-6
Published
2026 Aug
Container
Neurology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-00948-6,
  title = {Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.},
  author = {Jost WH and Bergquist F and Evans A and Hassin-Baer S and Hauser RA and Henriksen T and Malaty IA and Mestre TA and Mir P and Rodriguez R and Schwingenschuh P and Simu M and Bergmann L and Zhou TT and Caughlin S and Gopalkrishnan M and Kukreja P and O'Meara M and Parra JC and Shah MB and Aldred J},
  year = {2026},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-026-00948-6},
  url = {https://doi.org/10.1007/s40120-026-00948-6}
}

RIS

TY  - JOUR
TI  - Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.
AU  - Jost WH
AU  - Bergquist F
AU  - Evans A
AU  - Hassin-Baer S
AU  - Hauser RA
AU  - Henriksen T
AU  - Malaty IA
AU  - Mestre TA
AU  - Mir P
AU  - Rodriguez R
AU  - Schwingenschuh P
AU  - Simu M
AU  - Bergmann L
AU  - Zhou TT
AU  - Caughlin S
AU  - Gopalkrishnan M
AU  - Kukreja P
AU  - O'Meara M
AU  - Parra JC
AU  - Shah MB
AU  - Aldred J
PY  - 2026
JO  - Neurology and therapy
DO  - 10.1007/s40120-026-00948-6
UR  - https://doi.org/10.1007/s40120-026-00948-6
ER  - 

APA

WH, J., F, B., A, E., S, H., RA, H., T, H., IA, M., TA, M., P, M., R, R., P, S., M, S., L, B., TT, Z., S, C., M, G., P, K., M, O., JC, P., MB, S., & J, A. (2026). Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.. Neurology and therapy. https://doi.org/10.1007/s40120-026-00948-6

Source records